Comparison of CYP3A5*3 genotyping assays for personalizing immunosuppressive therapy in heart transplant patients .
CONCLUSION: Compared with a laboratory-based assay, the point-of-care assay that utilizes GTS-7000® is accurate and rapid despite being slightly more expensive. Further trials using this assay are warranted.
.
PMID: 30900981 [PubMed - as supplied by publisher]
Source: International Journal of Clinical Pharmacology and Therapeutics - Category: Drugs & Pharmacology Tags: Int J Clin Pharmacol Ther Source Type: research
More News: Cardiology | Cardiovascular | Drugs & Pharmacology | Genetics | Heart | Heart Transplant | Laboratory Medicine | Study | Transplant Surgery | Transplants